title: ENT manifestations of relapsing polychondritis.
abstract: Relapsing polychondritis is a rare disease probably of auto-immune etiology comprising inflammatory involvement of cartilage as well as phenomena of vasculitis. ENT manifestations are frequent and the authors present a case involving chondritis of the auricle, the nasal septum and affecting the cochleo-vestibular system as well. The diagnosis is based on the evocative clinical picture and on histological confirmation. Treatment consists of corticosteroids and immunosuppressive agents.
authors.affiliation: Dept ENT, Head and Neck Surgery, IMC Ixelles, Brussels, Belgium.
authors.forename: O
authors.initials: O
authors.lastname: Rampelberg
authors.forename: J M
authors.initials: JM
authors.lastname: Gerard
authors.forename: B
authors.initials: B
authors.lastname: Namias
authors.forename: M
authors.initials: M
authors.lastname: Gerard
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D015834:Cochlear Diseases / Q000188:drug therapy / Q000473:pathology*; D004427:Ear Diseases / Q000188:drug therapy / Q000473:pathology; D004431:Ear, External / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009300:Nasal Septum / Q000473:pathology*; D009668:Nose Diseases / Q000188:drug therapy / Q000473:pathology; D010034:Otitis Media with Effusion / Q000473:pathology; D011081:Polychondritis, Relapsing / Q000188:drug therapy / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use; D015837:Vestibular Diseases / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine